International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

Effectiveness and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris: A randomized controlled trial

Yazarlar: Sundiep Kumar, Jaishree Noor, Vijay Prakash Gupta

Cilt 5 , Sayı 3 , 2022 , Sayfalar 21-23

Konular:-

Anahtar Kelimeler:Tinea cruris,Sertaconazole,Terbinafine,Efficacy

Özet: Introduction: we compare the efficacy of topical terbinafine hydrochloride 1%, a fungicidal agent and sertaconazole nitrate 2% cream, a fungistatic agent in localized tinea corporis and tinea cruris and to study the adverse effects of these antifungal creams. Materials and Methods: 80 treatment naive individuals with tinea cruris were randomized into two groups of 30 each of 1:1 ratio using computer random sequence generator (www.randomization. com) to receive either topical terbinafine applied twice daily or topical sertaconazole once daily for a period of 4 weeks. The study pro forma included demographic details of patient, concomitant drugs taken, medical history, and physical and clinical examination which record vitals of patients. Results: At the baseline, composite score of all clinical symptoms was 5.11 ± 1.06 in the terbinafine group and 5.61 ± 1.15 in the sertaconazole group which was matched (P = 0.85). At the end of treatment (4 weeks), total composite score was 0.09 ± 0.21 in the terbinafine group and 0.04 ± 0.19 in the sertaconazole group which showed statistical significance (P < 0.001). Table 2 shows intragroup comparison of mean scores of two groups. Conclusion: Terbinafine was equal in efficacy and safety to newer azole – sertaconazole in treating patients with tinea cruris.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2022, title={Effectiveness and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris: A randomized controlled trial}, volume={5}, number={21–23}, publisher={International Journal of Health and Clinical Research}, author={Sundiep Kumar,Jaishree Noor,Vijay Prakash Gupta}, year={2022} }
APA
KOPYALA
Sundiep Kumar,Jaishree Noor,Vijay Prakash Gupta. (2022). Effectiveness and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris: A randomized controlled trial (Vol. 5). Vol. 5. International Journal of Health and Clinical Research.
MLA
KOPYALA
Sundiep Kumar,Jaishree Noor,Vijay Prakash Gupta. Effectiveness and Safety of Topical 1% Terbinafine versus Topical 2% Sertaconazole in Patients with Tinea Cruris: A Randomized Controlled Trial. no. 21–23, International Journal of Health and Clinical Research, 2022.